Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

SIRT5 Regulates Energy Metabolism and Survival in Acute Lymphoblastic Leukemia Cells

Nataly Cruz-Rodriguez, Dongqing Yan, Briana Bates, Daniela Uribe-Cano, Tony Pomicter, Michael Deininger

Blood (2023) 142 (Supplement 1): 41.

https://doi.org/10.1182/blood-2023-174967

Published: 2023

Journal Articles

Addiction to Small Gtpase ARF6-Mediated Sphingolipid Homeostasis By AML but Not the Host

Helong Gary Gary Zhao, Kent Johnson, Tony Pomicter, Briana Bates, Benjamin Bateman, Jonathan Ahmann, Jenna Bishop, Dongqing Yan, Greg Lee, Torsten Haferlach, Weiquan Zhu, Shannon Odelberg, Michael Deininger

Blood (2023) 142 (Supplement 1): 1384.

https://doi.org/10.1182/blood-2023-174155

Published: 2023

Journal Articles

MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis

Blood (2022) 139 (5): 761–778.

https://doi.org/10.1182/blood.2021011802

Published: 2022

Includes: Supplemental data

Journal Articles

MS4A3 Promotes Differentiation in Chronic Myeloid Leukemia By Enhancing Common β Chain Cytokine Receptor Endocytosis

Blood (2021) 138 (Supplement 1): 59.

https://doi.org/10.1182/blood-2021-151559

Published: 2021

Journal Articles

JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera

Blood (2019) 134 (26): 2388–2398.

https://doi.org/10.1182/blood.2019001385

Published: 2019

Includes: Supplemental data

Journal Articles

Combining the Allosteric ABL1 Inhibitor Asciminib (ABL001) with Ponatinib Suppresses Emergence of and Restores Efficacy Against Highly Resistant BCR-ABL1 Compound Mutants

Blood (2019) 134 (Supplement_1): 188.

https://doi.org/10.1182/blood-2019-131781

Published: 2019

Journal Articles

Molecular Alterations in Chronic Myelomonocytic Leukemia Monocytes: Transcriptional and Methylation Profiling

Anca Franzini, PhD, Jamshid S Khorashad, MD PhD, Hein Than, MD FRCPath, MRCP, Anthony D. Pomicter, MS, Dongqing Yan, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD

Blood (2018) 132 (Supplement 1): 3889.

https://doi.org/10.1182/blood-2018-99-115077

Published: 2018

Journal Articles

Combining Dasatinib and AC220 Reduces Stroma-Based pSTAT5Y694 in FLT3-ITD+ AML and Overcomes FLT3 TKI Resistance

Ami B. Patel, MD, Anthony D. Pomicter, MS, Dongqing Yan, Anna M. Eiring, PhD, Anca Franzini, PhD, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD

Blood (2018) 132 (Supplement 1): 2641.

https://doi.org/10.1182/blood-2018-99-117276

Published: 2018

Journal Articles

SIRT5 As a Therapeutic Target in Acute Myeloid Leukemia

Dongqing Yan, Anthony D. Pomicter, MS, William L. Heaton, MS, Clint C. Mason, PhD, Jonathan Ahmann, BS, Anna Senina, MS, Anca Franzini, PhD, Brayden Halverson, Hein Than, MD FRCPath, MRCP, Phillip M. Clair, MS, Jamshid S Khorashad, MD PhD, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD

Blood (2018) 132 (Supplement 1): 907.

https://doi.org/10.1182/blood-2018-99-115468

Published: 2018

Journal Articles

Inhibition of Nucleocytoplasmic Export Enhances Selective Elimination of Leukemic Stem Cells in Chronic Myeloid Leukemia

Hein Than, MD FRCPath, MRCP, Anthony D. Pomicter, MS, Clinton C. Mason, PhD, Anna M. Eiring, PhD, William L. Heaton, MS, Dongqing Yan, Anna Senina, MS, Phillip M. Clair, MS, Tessa L. Holyoake, MD PhD FRCP, FRCPath, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD

Blood (2017) 130 (Supplement 1): 42.

https://doi.org/10.1182/blood.V130.Suppl_1.42.42

Published: 2017

Journal Articles

Persistence of Somatic Mutation Spectrum and Clonal Architecture in Chronic Myelomonocytic Leukemia Treated with Hypomethylating Agents

Hein Than, MD FRCPath, MRCP, Yi Qiao, PhD, Xiaomeng Huang, PhD, Dongqing Yan, Jamshid Sorouri Khorashad, MD PhD FRCPath, Anthony D. Pomicter, MS, Anca Franzini, PhD, Tibor Kovacsovics, Thomas O'Hare, PhD, Gabor T. Marth, DSc, Michael W. Deininger, MD PhD

Blood (2017) 130 (Supplement 1): 2527.

https://doi.org/10.1182/blood.V130.Suppl_1.2527.2527

Published: 2017

Journal Articles

Selective Inhibition of Nucleocytoplasmic Transport Overcomes Ruxolitinib Resistance in Myelofibrosis

Dongqing Yan, Srinivas K. Tantravahi, MBBS, Anthony D. Pomicter, MS, Clinton C. Mason, PhD, Anna Senina, MS, Qiang Wang, PhD, Jamshid Sorouri Khorashad, MD PhD FRCPath, Hein Than, MD FRCPath, MRCP, Phillip M. Clair, MS, William L. Heaton, MS, Anna M. Eiring, PhD, Josef T. Prchal, MD, Sabina I. Swierczek, PhD, Erkan Baloglu, Sharon Shacham, PhD MBA, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD

Blood (2017) 130 (Supplement 1): 1660.

https://doi.org/10.1182/blood.V130.Suppl_1.1660.1660

Published: 2017

Journal Articles

A Novel JAK2 Mutation Confers Cytokine-Independence in the Absence of a Type I Dimeric Cytokine Receptor

Ami B. Patel, MD, Anca Franzini, PhD, Emilie Leroy, PhD, Dongqing Yan, Anna M. Eiring, PhD, Stefan N. Constantinescu, MD PhD, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD

Blood (2017) 130 (Supplement 1): 4212.

https://doi.org/10.1182/blood.V130.Suppl_1.4212.4212

Published: 2017

Journal Articles

Selective Inhibition of Nuclear Cytoplasmic Transport As a New Treatment Paradigm in Myelofibrosis

Dongqing Yan, PhD, Srinivas K. Tantravahi, MD, Anthony D. Pomicter, MS, Anna Senina, MS, Kevin C. Gantz, Hannah M. Redwine, Josef T. Prchal, MD, Sabina Swierczek, PhD, Phillip M. Clair, MS, Anna M. Eiring, PhD, Erkan Baloglu, PhD MBA, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD

Blood (2016) 128 (22): 636.

https://doi.org/10.1182/blood.V128.22.636.636

Published: 2016

Journal Articles

Transition of Chronic Myeloid Leukemia to Chronic Myelomonocytic Leukemia As a Tool to Observe Development of Chronic Myelomonocytic Leukemia

Jamshid S Khorashad, MD PhD, Srinivas K Tantravahi, Dongqing Yan, PhD, Anna M. Eiring, PhD, Hannah M. Redwine, Amber D. Bowler, Kevin C. Gantz, Keith M Gligorich, PhD, Anthony D Pomicter, MS, Todd W Kelley, MD, Thomas O'Hare, PhD, Michael W Deininger, MD PhD

Blood (2015) 126 (23): 5223.

https://doi.org/10.1182/blood.V126.23.5223.5223

Published: 2015

Journal Articles

Critical Role of SHP2 in the Initiation and Maintenance of Myeloproliferative Neoplasms Evoked By JAK2V617F

Golam Mohi, PhD, Dongqing Yan, PhD, Fatoumata Jobe, Robert E Hutchison, MD

Blood (2015) 126 (23): 483.

https://doi.org/10.1182/blood.V126.23.483.483

Published: 2015

Journal Articles

Stat3 Negatively Regulates Myeloproliferative Neoplasm Induced By Jak2V617F

Dongqing Yan, Ph.D., Golam Mohi, PhD

Blood (2013) 122 (21): 111.

https://doi.org/10.1182/blood.V122.21.111.111

Published: 2013

Journal Articles

Loss of Wild-Type Jak2 Allele Enhances Myeloid Cell Expansion and Accelerates Myelofibrosis in Jak2V617F Knock-in Mice

Hajime Akada, Saeko Akada, Dongqing Yan, Robert Hutchison, MD, Golam Mohi, PhD

Blood (2012) 120 (21): 809.

https://doi.org/10.1182/blood.V120.21.809.809

Published: 2012

Journal Articles

Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice

Dongqing Yan, Robert E. Hutchison, Golam Mohi

Blood (2012) 120 (9): 1888–1898.

https://doi.org/10.1182/blood-2011-09-380808

Published: 2012

Includes: Supplemental data

Journal Articles

Critical requirement for Stat5 in a mouse model of polycythemia vera

Dongqing Yan, Robert E. Hutchison, Golam Mohi

Blood (2012) 119 (15): 3539–3549.

https://doi.org/10.1182/blood-2011-03-345215

Published: 2012

Includes: Supplemental data

NARROW

SIRT5 Regulates Energy Metabolism and Survival in Acute Lymphoblastic Leukemia Cells

Addiction to Small Gtpase ARF6-Mediated Sphingolipid Homeostasis By AML but Not the Host

MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis

MS4A3 Promotes Differentiation in Chronic Myeloid Leukemia By Enhancing Common β Chain Cytokine Receptor Endocytosis

JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera

Combining the Allosteric ABL1 Inhibitor Asciminib (ABL001) with Ponatinib Suppresses Emergence of and Restores Efficacy Against Highly Resistant BCR-ABL1 Compound Mutants

Molecular Alterations in Chronic Myelomonocytic Leukemia Monocytes: Transcriptional and Methylation Profiling

Combining Dasatinib and AC220 Reduces Stroma-Based pSTAT5Y694 in FLT3-ITD+ AML and Overcomes FLT3 TKI Resistance

SIRT5 As a Therapeutic Target in Acute Myeloid Leukemia

Inhibition of Nucleocytoplasmic Export Enhances Selective Elimination of Leukemic Stem Cells in Chronic Myeloid Leukemia

Persistence of Somatic Mutation Spectrum and Clonal Architecture in Chronic Myelomonocytic Leukemia Treated with Hypomethylating Agents

Selective Inhibition of Nucleocytoplasmic Transport Overcomes Ruxolitinib Resistance in Myelofibrosis

A Novel JAK2 Mutation Confers Cytokine-Independence in the Absence of a Type I Dimeric Cytokine Receptor

Selective Inhibition of Nuclear Cytoplasmic Transport As a New Treatment Paradigm in Myelofibrosis

Transition of Chronic Myeloid Leukemia to Chronic Myelomonocytic Leukemia As a Tool to Observe Development of Chronic Myelomonocytic Leukemia

Critical Role of SHP2 in the Initiation and Maintenance of Myeloproliferative Neoplasms Evoked By JAK2V617F

Stat3 Negatively Regulates Myeloproliferative Neoplasm Induced By Jak2V617F

Loss of Wild-Type Jak2 Allele Enhances Myeloid Cell Expansion and Accelerates Myelofibrosis in Jak2V617F Knock-in Mice

Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice

Critical requirement for Stat5 in a mouse model of polycythemia vera

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only